Report Detail

Pharma & Healthcare Europe Branded Generics Market Report 2019

  • RnM3867138
  • |
  • 16 January, 2020
  • |
  • Global
  • |
  • 115 Pages
  • |
  • XYZResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Branded Generics Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Value Added Branded Generics Market Performance (Volume)
      • 2.1.2 Trade (Brand) Named Generics Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Value Added Branded Generics Market Performance (Value)
      • 2.2.2 Trade (Brand) Named Generics Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospital Pharmacies Market Performance (Volume)
      • 3.1.2 Retail Pharmacies Market Performance (Volume)
      • 3.1.3 Online Pharmacies Market Performance (Volume)
      • 3.1.4 Drug Stores Market Performance (Volume)
      • 3.1.5 Others Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Abbott Laboratories
      • 4.1.1 Abbott Laboratories Profiles
      • 4.1.2 Abbott Laboratories Product Information
      • 4.1.3 Abbott Laboratories Branded Generics Business Performance
      • 4.1.4 Abbott Laboratories Branded Generics Business Development and Market Status
    • 4.2 Apotex
      • 4.2.1 Apotex Profiles
      • 4.2.2 Apotex Product Information
      • 4.2.3 Apotex Branded Generics Business Performance
      • 4.2.4 Apotex Branded Generics Business Development and Market Status
    • 4.3 AstraZeneca
      • 4.3.1 AstraZeneca Profiles
      • 4.3.2 AstraZeneca Product Information
      • 4.3.3 AstraZeneca Branded Generics Business Performance
      • 4.3.4 AstraZeneca Branded Generics Business Development and Market Status
    • 4.4 Dr.Reddy’s Laboratories
      • 4.4.1 Dr.Reddy’s Laboratories Profiles
      • 4.4.2 Dr.Reddy’s Laboratories Product Information
      • 4.4.3 Dr.Reddy’s Laboratories Branded Generics Business Performance
      • 4.4.4 Dr.Reddy’s Laboratories Branded Generics Business Development and Market Status
    • 4.5 GlaxoSmithKline
      • 4.5.1 GlaxoSmithKline Profiles
      • 4.5.2 GlaxoSmithKline Product Information
      • 4.5.3 GlaxoSmithKline Branded Generics Business Performance
      • 4.5.4 GlaxoSmithKline Branded Generics Business Development and Market Status
    • 4.6 Hospira
      • 4.6.1 Hospira Profiles
      • 4.6.2 Hospira Product Information
      • 4.6.3 Hospira Branded Generics Business Performance
      • 4.6.4 Hospira Branded Generics Business Development and Market Status
    • 4.7 Lupin
      • 4.7.1 Lupin Profiles
      • 4.7.2 Lupin Product Information
      • 4.7.3 Lupin Branded Generics Business Performance
      • 4.7.4 Lupin Branded Generics Business Development and Market Status
    • 4.8 Mylan N.V
      • 4.8.1 Mylan N.V Profiles
      • 4.8.2 Mylan N.V Product Information
      • 4.8.3 Mylan N.V Branded Generics Business Performance
      • 4.8.4 Mylan N.V Branded Generics Business Development and Market Status
    • 4.9 Novartis AG
      • 4.9.1 Novartis AG Profiles
      • 4.9.2 Novartis AG Product Information
      • 4.9.3 Novartis AG Branded Generics Business Performance
      • 4.9.4 Novartis AG Branded Generics Business Development and Market Status
    • 4.10 Par Pharmaceutical
      • 4.10.1 Par Pharmaceutical Profiles
      • 4.10.2 Par Pharmaceutical Product Information
      • 4.10.3 Par Pharmaceutical Branded Generics Business Performance
      • 4.10.4 Par Pharmaceutical Branded Generics Business Development and Market Status
    • 4.11 Sandoz
    • 4.12 Sanofi
    • 4.13 Teva Pharmaceutical
    • 4.14 Valeant
    • 4.15 ZydusCadila
    • 4.16 Others

    5 Market Performance for Manufacturers

    • 5.1 Europe Branded Generics Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Europe Branded Generics Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Europe Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Europe Branded Generics Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Germany Market Performance for Manufacturers
      • 6.1.1 Germany Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 Germany Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 Germany Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 Germany Branded Generics Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 UK Market Performance for Manufacturers
      • 6.2.1 UK Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 UK Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 UK Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 UK Branded Generics Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 France Market Performance for Manufacturers
      • 6.3.1 France Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 France Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 France Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 France Branded Generics Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Russia Market Performance for Manufacturers
      • 6.4.1 Russia Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Russia Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Russia Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Russia Branded Generics Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Benelux Market Performance for Manufacturers
      • 6.5.1 Benelux Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Benelux Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Benelux Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Benelux Branded Generics Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 Italy Market Performance for Manufacturers
      • 6.6.1 Italy Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 Italy Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 Italy Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 Italy Branded Generics Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Spain Market Performance for Manufacturers
      • 6.7.1 Spain Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Spain Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Spain Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Spain Branded Generics Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 Branded Generics Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Europe Branded Generics Market Performance (Sales Point)

    • 7.1 Europe Branded Generics Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Europe Branded Generics Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Europe Branded Generics Price (USD/Unit) by Regions 2014-2020
    • 7.4 Europe Branded Generics Gross Margin by Regions 2014-2020

    8 Development Trend for Regions (Sales Point)

    • 8.1 Europe Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.2 Germany Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.3 UK Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 France Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.5 Russia Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.6 Benelux Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.7 Italy Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.8 Spain Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Hospital Pharmacies Industry
    • 11.2 Retail Pharmacies Industry
    • 11.3 Online Pharmacies Industry
    • 11.4 Drug Stores Industry
    • 11.5 Others Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Europe Branded Generics Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Europe Branded Generics Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 Germany Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 UK Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 France Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Russia Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Benelux Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 Italy Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Spain Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 Value Added Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.3 Trade (Brand) Named Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.3 Sales Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Hospital Pharmacies Sales and and Growth Rate 2021-2026
      • 12.3.3 Retail Pharmacies Sales and and Growth Rate 2021-2026
      • 12.3.4 Online Pharmacies Sales and and Growth Rate 2021-2026
      • 12.3.5 Drug Stores Sales and and Growth Rate 2021-2026
      • 12.3.6 Others Sales and and Growth Rate 2021-2026
    • 12.4 Price (USD/Unit) and Gross Profit Forecast
      • 12.4.1 Europe Branded Generics Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Europe Branded Generics Gross Profit Trend 2021-2026

    13 Conclusion

    In this report, our team research the Europe Branded Generics market by type, application, region and manufacturer 2014-2020 and forcast 2021-2026. For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.

    Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Branded Generics for these regions, from 2014 to 2026 (forecast), including
    Germany
    UK
    France
    Russia
    Benelux
    Italy
    Spain

    Europe Branded Generics market competition by top manufacturers/players, with Branded Generics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Laboratories
    Apotex
    AstraZeneca
    Dr.Reddy’s Laboratories
    GlaxoSmithKline
    Hospira
    Lupin
    Mylan N.V
    Novartis AG
    Par Pharmaceutical
    Sandoz
    Sanofi
    Teva Pharmaceutical
    Valeant
    ZydusCadila
    Others

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Value Added Branded Generics
    Trade (Brand) Named Generics

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Branded Generics for each application, including
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Drug Stores
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.


    Summary:
    Get latest Market Research Reports on Europe Branded Generics. Industry analysis & Market Report on Europe Branded Generics is a syndicated market report, published as Europe Branded Generics Market Report 2019. It is complete Research Study and Industry Analysis of Europe Branded Generics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,450.00
    $6,800.00
    2,638.49
    5,200.50
    2,931.30
    5,777.63
    365,375.70
    720,160.80
    258,853.50
    510,204.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report